Hyperglycaemia (Diabetic)
16
5
5
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
19%
3 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (16)
Validation of Remote Photoplethysmography for Non-Invasive Estimation of Blood Glucose and HbA1c
Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes
Peripheral Nerve Blocks for Above-the-knee Amputations
Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant
Effect of Hyperglycaemia and Moxifloxacin on QTc Interval in T2DM
Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)
The Effect of Omega-3 FA on Glucose and Lipid Homeostasis Disorders in Obese/Diabetic Patients
Insulin Therapy for Postreperfusion Hyperglycemia
The SHINE Study: Safety of Implant and Preliminary Performance of the SHINE SYSTEM in Diabetic Subjects
Investigating the Role of the Polyol Pathway in the Central Nervous System Production of Fructose
Microclinic Social Network Behavioral Health Trial in Jordan
Perioperative Evaluation of Glucose Profile Using Continuous Glucose Monitoring System in Glucose Intolerant Patients
Hypoglycaemia and Cardiac Arrhythmias in Type 1 Diabetes
Development of Agents to Diminish the Risk of Hypoglycemia-induced Brain Injury in Type 1 Diabetes
Multiple Ascending Doses of Globalagliatin Hydrochloride in Type 2 Diabetes Mellitus
The Assessment of Single-Dose Safety,Tolerability, Pharmacokinetics and Pharmacodynamic of Globalagliatin Hydrochloride